Cell protection, resistance and invasiveness of two malignant mesotheliomas as assessed by 10K-microarray.

[1]  B. Robinson,et al.  Serologic responses in patients with malignant mesothelioma: evidence for both public and private specificities. , 2000, American journal of respiratory cell and molecular biology.

[2]  Y. Soini,et al.  Manganese superoxide dismutase as a diagnostic marker for malignant pleural mesothelioma , 2000, British Journal of Cancer.

[3]  J. Benichou,et al.  Malignant mesothelioma: attributable risk of asbestos exposure. , 1994, Occupational and environmental medicine.

[4]  H. Ariga,et al.  Tumour invasion and metastasis are promoted in mice deficient in tenascin‐X , 2001, Genes to cells : devoted to molecular & cellular mechanisms.

[5]  J. Yodoi,et al.  Cellular levels of thioredoxin associated with drug sensitivity to cisplatin, mitomycin C, doxorubicin, and etoposide. , 1995, Cancer research.

[6]  J. Schalken,et al.  Cadherin switching in human prostate cancer progression. , 2000, Cancer research.

[7]  D. Carey,et al.  Syndecans: multifunctional cell-surface co-receptors. , 1997, The Biochemical journal.

[8]  P. Bornstein,et al.  Thrombospondins as matricellular modulators of cell function. , 2001, The Journal of clinical investigation.

[9]  K. Raivio,et al.  Manganese superoxide dismutase in healthy human pleural mesothelium and in malignant pleural mesothelioma. , 1998, American journal of respiratory cell and molecular biology.

[10]  H. Takita,et al.  Malignant pleural mesothelioma: a problematic review. , 1998, Surgical oncology.

[11]  P. Stern,et al.  Immunohistological distribution of 5T4 antigen in normal and malignant tissues. , 1990, British Journal of Cancer.

[12]  H. Wong,et al.  The stress response and the lung. , 1997, The American journal of physiology.

[13]  S. Ramaswamy,et al.  Translation of microarray data into clinically relevant cancer diagnostic tests using gene expression ratios in lung cancer and mesothelioma. , 2002, Cancer research.

[14]  H. Kobayashi.  Suppression of urokinase expression and tumor metastasis by bikunin overexpression [mini-review]. , 2001, Human cell.

[15]  K. Koskinen,et al.  Glutathione S-transferase and N-acetyltransferase genotypes and asbestos-associated pulmonary disorders. , 1996, Journal of the National Cancer Institute.

[16]  I. Downie,et al.  Immunohistochemical analysis still has a limited role in the diagnosis of malignant mesothelioma. A study of thirteen antibodies. , 2001, American journal of clinical pathology.

[17]  D. Whitaker,et al.  Expression and integrity of DNA topoisomerase II isoforms does not explain generic drug resistance in malignant mesothelioma , 2001, Cancer Chemotherapy and Pharmacology.

[18]  A. Hjerpe,et al.  Differentiation of mesothelioma cells is influenced by the expression of proteoglycans. , 2000, Experimental cell research.

[19]  Mark R. Green,et al.  Co‐ordinated over‐expression of the MRP and γ‐glutamylcysteine synthetase genes, but not MRD1, correlates with doxorubicin resistance in human malignant mesothelioma cell lines , 1998, International journal of cancer.

[20]  T. Horie,et al.  Expression of thioredoxin in bleomycin-injured airway epithelium: possible role of protection against bleomycin induced epithelial injury. , 2001, Life Science.

[21]  K. McManus,et al.  Increased nm23 immunoreactivity is associated with selective inhibition of systemic tumour cell dissemination. , 2002, Journal of clinical pathology.

[22]  H. Munro,et al.  Ferritin gene expression in health and malignancy. , 1992, Pathobiology : journal of immunopathology, molecular and cellular biology.

[23]  M. Herlyn,et al.  Abnormal protein tyrosine kinase gene expression during melanoma progression and metastasis , 1995, International journal of cancer.

[24]  V. Ferrans,et al.  Role of pleural mesothelial cells in the production of the submesothelial connective tissue matrix of lung. , 1984, The American review of respiratory disease.

[25]  T. Barth,et al.  Pleural mesothelioma mimics the integrin profile of activated, sessile rather than detached mesothelial cells , 1997, International journal of cancer.

[26]  P. Heldin,et al.  Hyaluronan receptors are expressed on human malignant mesothelioma cells but not on normal mesothelial cells. , 1994, Cancer research.

[27]  A. Ferrando,et al.  Structure and expression in breast tumors of human TIMP-3, a new member of the metalloproteinase inhibitor family. , 1994, Cancer research.

[28]  G. Leikauf,et al.  Differential gene expression in mesothelioma , 2000, FEBS letters.

[29]  B. Weyn,et al.  Expression profile of telomerase subunits in human pleural mesothelioma , 2000, The Journal of pathology.

[30]  W. Cliby,et al.  Elevated nm23 protein expression is correlated with diminished progression-free survival in patients with epithelial ovarian carcinoma. , 1996, Gynecologic oncology.

[31]  P. Stern,et al.  Metastasis-associated 5T4 oncofoetal antigen is concentrated at microvillus projections of the plasma membrane. , 1995, Journal of cell science.

[32]  A. Kinoshita,et al.  A Transcription Activator with Restricted Tissue Distribution Regulates Cell-specific Expression of α1(XI) Collagen* , 1997, The Journal of Biological Chemistry.

[33]  K. Pelin,et al.  Inherited GSTM1 and NAT2 defects as concurrent risk modifiers in asbestos-related human malignant mesothelioma. , 1995, Cancer research.

[34]  K. Khanna,et al.  ATM, a central controller of cellular responses to DNA damage , 2001, Cell Death and Differentiation.

[35]  N. Karamanos,et al.  Proteoglycans in human malignant mesothelioma. Stimulation of their synthesis induced by epidermal, insulin and platelet-derived growth factors involves receptors with tyrosine kinase activity. , 1999, Biochimie.

[36]  R. K. Bright,et al.  Thrombospondin‐1 expression and clinical implications in malignant pleural mesothelioma , 1999, Cancer.

[37]  G. Vollmer.  Expression of tenascin during carcinogenesis and involution of hormone-dependent tissues. , 1994, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[38]  J. Heino.  Biology of tumor cell invasion: Interplay of cell adhesion and matrix degradation , 1996, International journal of cancer.

[39]  Martin Kk,et al.  Nm23: an invasion suppressor gene in CNS tumours? , 1998 .

[40]  C. Verschraegen,et al.  Increased expression of heat shock protein 70 in adherent ovarian cancer and mesothelioma following treatment with manumycin, a farnesyl transferase inhibitor. , 2002, Anticancer research.

[41]  S. Byers,et al.  Cadherin-11 is expressed in invasive breast cancer cell lines. , 1999, Cancer research.

[42]  G. Leikauf,et al.  Microarrays as cancer keys: an array of possibilities. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  W Kühnel,et al.  Invasiveness of human pleural mesothelioma cells is influenced in vitro by the three-dimensional structure of the ECM and its composition. , 2002, Annals of anatomy = Anatomischer Anzeiger : official organ of the Anatomische Gesellschaft.

[44]  A. Ochiai,et al.  Simultaneous expression of cadherin-11 in signet-ring cell carcinoma and stromal cells of diffuse-type gastric cancer. , 1996, Cancer letters.

[45]  P. Stern,et al.  Oncofetal antigen 5T4 expression as a prognostic factor in patients with gastric cancer. , 2002, Anticancer research.

[46]  N. Karamanos,et al.  Glycosaminoglycans from two human malignant mesothelioma cell lines: determination, distribution, and effect of platelet-derived growth factor on their synthesis. , 1995, Biochemistry and cell biology = Biochimie et biologie cellulaire.

[47]  M. Maruyama,et al.  Immunohistochemical demonstration of bikunin, a light chain of inter-α-trypsin inhibitor, in human brain tumors , 1994, Inflammation.

[48]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[49]  H. Friess,et al.  Cloning of a new Kunitz-type protease inhibitor with a putative transmembrane domain overexpressed in pancreatic cancer. , 1998, Biochimica et biophysica acta.

[50]  G. Rechavi,et al.  Absence of p53 mutations in malignant mesotheliomas. , 1997, American journal of respiratory cell and molecular biology.

[51]  R. Gatti.  The Inherited Basis of Human Radiosensitivity , 2001, Acta oncologica.

[52]  F Levi,et al.  The European mesothelioma epidemic , 1999, British Journal of Cancer.

[53]  R. Savani,et al.  Overexpression of the hyaluronan receptor RHAMM is transforming and is also required for H-ras transformation , 1995, Cell.

[54]  W. Dehnen,et al.  mRNA expression patterns in different stages of asbestos-induced carcinogenesis in rats. , 2000, Carcinogenesis.

[55]  G. Powis,et al.  Thioredoxin, a gene found overexpressed in human cancer, inhibits apoptosis in vitro and in vivo. , 1997, Cancer research.

[56]  T. Hei,et al.  Differentially expressed genes in asbestos-induced tumorigenic human bronchial epithelial cells: implication for mechanism. , 2000, Carcinogenesis.

[57]  S. Knuutila,et al.  Gene expression profiling of malignant mesothelioma cell lines: cDNA array study , 2001, International journal of cancer.

[58]  E. Liu,et al.  Receptor tyrosine kinases expressed in metastatic colon cancer , 1995, International journal of cancer.

[59]  Deĭchman Gi.  Natural selection and early changes of phenotype of tumor cells in vivo: acquisition of new defense mechanisms. , 2000 .

[60]  T. H. van der Kwast,et al.  EXPRESSION OF ICAM‐1 AND VCAM‐1 IN HUMAN MALIGNANT MESOTHELIOMA , 1996, The Journal of pathology.

[61]  K. Pelin,et al.  Manganese superoxide dismutase in human pleural mesothelioma cell lines. , 1996, Free radical biology & medicine.

[62]  A. Holmgren,et al.  Up‐regulation of thioredoxin and thioredoxin reductase in human malignant pleural mesothelioma , 2001, International journal of cancer.

[63]  A. Aust,et al.  Induction of ferritin synthesis in human lung epithelial cells treated with crocidolite asbestos. , 1997, Archives of biochemistry and biophysics.

[64]  S. Goodison,et al.  Contrasting expression of thrombospondin-1 and osteopontin correlates with absence or presence of metastatic phenotype in an isogenic model of spontaneous human breast cancer metastasis. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.

[65]  P. L. Chen,et al.  NBS1 and TRF1 Colocalize at Promyelocytic Leukemia Bodies during Late S/G2 Phases in Immortalized Telomerase-negative Cells , 2000, The Journal of Biological Chemistry.

[66]  X. Sun,et al.  Upregulation of 9 genes, including that for thioredoxin, during epithelial differentiation of mesothelioma cells. , 2000, Differentiation; research in biological diversity.

[67]  B. Rihn,et al.  Microdissection, mRNA amplification and microarray: a study of pleural mesothelial and malignant mesothelioma cells. , 2004, Biochimie.

[68]  J. Thiery,et al.  Cadherin 11 expression marks the mesenchymal phenotype: towards new functions for cadherins? , 1995, Cell adhesion and communication.

[69]  A. Ivanoff,et al.  Expression and activity of matrix metalloproteases in human malignant mesothelioma cell lines , 2001, International journal of cancer.

[70]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[71]  Y. Soini,et al.  Overexpression of γ-glutamylcysteine synthetase in human malignant mesothelioma , 2002 .

[72]  Y. Soini,et al.  Tenascin Expression and Distribution in Pleural Inflammatory and Fibrotic Diseases , 2000, The journal of histochemistry and cytochemistry : official journal of the Histochemistry Society.

[73]  H. Pass,et al.  High CD44 expression on human mesotheliomas mediates association with hyaluronan. , 1995, The cancer journal from Scientific American.

[74]  S Baba,et al.  Levels of alpha 2 macroglobulin can predict bone metastases in prostate cancer. , 2001, Anticancer research.

[75]  K. Pelin,et al.  Gap junctional intercellular communication of primary and asbestos-associated malignant human mesothelial cells. , 1993, Carcinogenesis.

[76]  J. Blumenstock,et al.  Using gene expression ratios to predict outcome among patients with mesothelioma. , 2003, Journal of the National Cancer Institute.

[77]  P. Watson,et al.  The overexpression of RHAMM, a hyaluronan-binding protein that regulates ras signaling, correlates with overexpression of mitogen-activated protein kinase and is a significant parameter in breast cancer progression. , 1998, Clinical cancer research : an official journal of the American Association for Cancer Research.

[78]  Michael Dohn,et al.  Receptor tyrosine kinase EphA2 is regulated by p53-family proteins and induces apoptosis , 2001, Oncogene.

[79]  J. Hogg,et al.  Proteoglycans in granulomatous lung diseases. , 1997, The European respiratory journal.

[80]  E. Brambilla,et al.  Overexpression of nucleoside diphosphate/kinase A/nm23-H1 protein in human lung tumors: association with tumor progression in squamous carcinoma. , 1996, Laboratory investigation; a journal of technical methods and pathology.

[81]  M. Detmar,et al.  Thrombospondin‐2 plays a protective role in multistep carcinogenesis: a novel host anti‐tumor defense mechanism , 2001, The EMBO journal.

[82]  A. Harris,et al.  The distribution and expression of the two isoforms of DNA topoisomerase II in normal and neoplastic human tissues. , 1997, British Journal of Cancer.

[83]  Yasunosuke Suzuki,et al.  Asbestos Fibers Contributing to the Induction of Human Malignant Mesothelioma , 2002, Annals of the New York Academy of Sciences.

[84]  K. Matsumoto,et al.  Extracellular matrix tenascin‐X in combination with vascular endothelial growth factor B enhances endothelial cell proliferation , 2000, Genes to cells : devoted to molecular & cellular mechanisms.

[85]  H. Kobayashi,et al.  Inhibition of the soluble and the tumor cell receptor-bound plasmin by urinary trypsin inhibitor and subsequent effects on tumor cell invasion and metastasis. , 1994, Cancer research.

[86]  D. Bostwick,et al.  Overexpression of the EphA2 tyrosine kinase in prostate cancer , 1999, The Prostate.